Mondaq India: Food, Drugs, Healthcare, Life Sciences > Healthcare
Nishith Desai Associates
The Indian Government has had a busy 2019 so far with respect to healthcare regulation. From passing the controversial National Medical Commission Act, 2019 through
AMLEGALS
The focus of the regulation is to make the Companies accountable for their claims on food products and cater to the interest of customers.
Cyril Amarchand Mangaldas
In the backdrop of recent attacks and acts of violence against medical practitioners and a growing demand for protection in this regard
Cyril Amarchand Mangaldas
The National Medical Commission Act, 2019 (NMC Act) has been notified vide the Gazette Notification dated August 8, 2019.
S.S. Rana & Co. Advocates
Since time immemorial, India has been one of the most preferred sources of procuring products for sale in the market worldwide.
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
AZB & Partners
Some authorities have issued separate handbooks in the context of the leased lands, which impose additional restrictions as well.
AZB & Partners
On June 20, 2019, CCI penalised Jalgaon District Medicine Dealers Association (‘JDMDA') as well as its office bearers, i.e., the President and Secretary of JDMDA
AZB & Partners
On May 22, 2019, CCI approved the merger of certain consumer healthcare products of GlaxoSmithKline Plc. (‘GSK') and Pfizer Inc. (‘Pfizer', together with GSK
Singh & Associates
Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.
Singh & Associates
The ownership and licensing policies associated with the innovations plays a major role in the promotion of effective deployment of general public funds and research and development programmes.
Khurana and Khurana
Flipkart, one of the most trusted Ecommerce website recently ended up settling a legal dispute with an Indian health and fitness brand, GOQii as it was allegedly running into loses because its products were discounted up to 70% ...
Singh & Associates
This segment of the newsletter is focused on regulatory reforms from Healthcare and Pharmaceutical sectors in the Indian jurisdiction with collated information on monthly basis via c
Singh & Associates
The Homeopathy Central Council Act, 1973, was established to deal with the education and practice of homeopathy.
Singh & Associates
The DG submitted the "Main Investigation Report" upon completion of investigation.
Singh & Associates
Impact of ENDS on Public Health ENDS or e-cigarettes are battery operated smoking devices.
Singh & Associates
On June 17, 2019, a report on ‘The Indian pharmaceutical industry – the way forward' was published by an Indian Pharmaceutical Alliance representing research based pharmaceutical companies ...
Singh & Associates
The Pharmacovigilance Programme of India, was first introduced in the year 2010 to improve safety of Indian population by monitoring drug related Adverse Drug Reactions collected via ADR monitoring centers ...
Singh & Associates
On June 06, 2019, Directorate of Health Services, Kerala released the first of its kind interim guidelines on management of Nipah Virus (NiV) infection.
Cyril Amarchand Mangaldas
Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
Most Popular Recent Articles
NovoJuris Legal
The Personal Data Protection Bill, 2018 and the Data Protection Committee's Report (released on 27 July 2018) contains the framework and the policymakers' insight on protection of personal data in India.
Singh & Associates
The Rules introduced the conditions for providing post-trial access of drugs to patients who require it for the first time.
Khurana and Khurana
Trademarks play a vital role in creating a brand name and goodwill of any business. Not only does it helps in creating a brand value but also, aids in revenue generation.
Singh & Associates
The ownership and licensing policies associated with the innovations plays a major role in the promotion of effective deployment of general public funds and research and development programmes.
Cyril Amarchand Mangaldas
Issues around payment of compensation in cases of clinical trial related injury, disability and death have long remained open. Despite a directive
Nishith Desai Associates
The first half of 2019 has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of 2018 - has taken a temporary backseat this year.
AZB & Partners
On May 22, 2019, CCI approved the merger of certain consumer healthcare products of GlaxoSmithKline Plc. (‘GSK') and Pfizer Inc. (‘Pfizer', together with GSK
Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013, under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
Nishith Desai Associates
The Indian Government has had a busy 2019 so far with respect to healthcare regulation. From passing the controversial National Medical Commission Act, 2019 through
Cyril Amarchand Mangaldas
The National Medical Commission Act, 2019 (NMC Act) has been notified vide the Gazette Notification dated August 8, 2019.
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with